2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model Biphasic bioceramic of tricalcium phosphate and hydroxyapatite with simvastatin, Bovine Hydroxyapatite - Bone Loss, Regenerative Inflammation | Phase 4 | Unknown | Mario Pérez Sayáns | 30 | 2024-03-02 | 2024-04-03 |
| BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study B/F/TAF, TDF/3TC/EFV or DTG or NVP, DMPA - Bone Loss | Phase 4 | Unknown | MU-JHU CARE | 330 | 2019-12-03 | 2023-04-07 |
Bone Diseases (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2)
Bio-Oss (1) · Durapatite (1) · Medroxyprogesterone Acetate (1) · N,N-dimethyl-4-anisidine (1) · Nevirapine (1) · Simvastatin (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · dolutegravir (1)
MU-JHU CARE (1) · Mario Pérez Sayáns (1)
Spain (1) · Uganda (1)